on BERLANDES
BERLANDES Introduces PCCIDINCT2™ Ovarian Capsules
HANGZHOU, CHINA - BERLANDES, a leader in cellular regeneration and biotechnology, has launched the PCCIDINCT2™ Ovarian Capsules. This innovative product aims to enhance ovarian health and tackle reproductive issues in women, supported by extensive research in biological sciences.
The capsules have been developed with cutting-edge technology and nanobiotechnology to repair cellular damage from the surface to the nucleus. The product's unique formula, created by Stephen John Williams BUSBY and his team, includes antioxidant ingredients, inositol with vitamin B9, and Neumentix™ Spearmint extract to support hormone balance, emotional well-being, and ovarian rejuvenation.
These capsules address symptoms like irregular cycles, lifestyle imbalances, fertility issues, and menopause signs. This launch represents a significant step for BERLANDES in its mission to advance women’s health worldwide.
R. E.
Copyright © 2024 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all BERLANDES news